Frontlight ResearchEarly access
Trial site
IRCCS - Istituto Romagnolo per lo Studio Dei Tumori, Dino Amadori
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 33 trials
- Phase 1/21 trial
- Status
- Recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- ABX advanced biochemical compounds GmbH1 trial
- Istituto Ortopedico Rizzoli1 trial
- Novartis Pharmaceuticals1 trial
- NovoCure GmbH1 trial
- Sumitomo Pharma America, Inc.1 trial
Running trials
Recruiting
Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Sarcoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026